Please use this identifier to cite or link to this item:
|Title:||Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA||Authors:||Chua, Y.L.
Mitochondrial permeability transition
Reactive oxygen species
|Issue Date:||2005||Citation:||Chua, Y.L., Zhang, D., Whiteman, M., Armstrong, J.S., Boelsterli, U., Moore, P.K. (2005). Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA. Biochemical and Biophysical Research Communications 337 (1) : 375-381. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbrc.2005.09.059||Abstract:||Oltipraz, a member of a class of 1,2-dithiolethiones, is a potent phase 2 enzyme inducing agent used as a cancer chemopreventive. In this study, we investigated regulation of the phase 2 enzyme response and protection against endogenous oxidative stress in lymphoblastic leukemic parental CEM cells and cells lacking mitochondrial DNA (mtDNA) (ρ0) by oltipraz. Glutathione (GSH) levels (total and mitochondrial) and glutathione S-transferase (GST) activity were significantly increased after pretreatment with oltipraz in both parental (ρ+) and ρ0 cells, and both cell lines were resistant to mitochondrial oxidation, loss of mitochondrial membrane potential, and cell death in response to the GSH depleting agent diethylmaleate. These results show that the phase 2 enzyme response, by enhancing GSH-dependent systems involved in xenobiotic metabolism, blocks endogenous oxidative stress and cell death, and that this response is intact in cells lacking mtDNA. © 2005 Elsevier Inc. All rights reserved.||Source Title:||Biochemical and Biophysical Research Communications||URI:||http://scholarbank.nus.edu.sg/handle/10635/27412||ISSN:||0006291X||DOI:||10.1016/j.bbrc.2005.09.059|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 10, 2020
WEB OF SCIENCETM
checked on Jul 2, 2020
checked on Jun 30, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.